The global molecular diagnostics market is estimated to reach US$17.96 billion in 2024, growing at a CAGR of 6.16% for the period spanning from 2020 to 2024. The factors such as rising emergence of infectious diseases rise in global ageing population, increasing incidence of cancer cases are expected to drive the market. However, growth of the industry will be challenged by high initial cost, dearth of trained professionals, urgent need for proper infrastructure and delay in the approval of new molecular diagnostic tests. A few notable trends include progressing sample-to-answer molecular diagnostics market, growth in point of care diagnostics (poct), booming medical devices industry, innovation and technical developments, emergence of liquid biopsy solutions, targeting anti-biotic resistance , decentralization of diagnostic testing, advances in genomics and proteomics.
The global molecular diagnostics market is segmented into, infectious diseases, oncology, genetics, blood screening, and tissue typing.
The global molecular diagnostics market is expected to grow in future mainly due to diagnosis of infectious diseases. In terms of geographical areas, North America is the major contributors to the global molecular diagnostics market supported by rising spread of infectious diseases and presence of a well-established diagnostic infrastructure, technological advancements. Asia Pacific represents the fastest growing market for molecular diagnostics with rapidly developing infrastructure and increasing investments in research and development.
Scope of the report:
• The report provides a comprehensive analysis of the global molecular diagnostics market, segmented into, infectious diseases, oncology, genetics, blood screening, and tissue typing. • The major regional markets (North America, Western Europe and Asia Pacific) have been analyzed. • The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth. • The competitive landscape of the market, along with the company profiles of leading players (Roche Holding AG, Abbott Laboratories, Danaher Corporation, Hologic Inc. , Biomerieux SA and Thermo Fisher Scientific Inc. ) are also presented in detail.
Key Target Audience:
• Diagnostics Product Manufacturers • End Users • Consulting Firms • Investment Banks • Government Bodies & Regulating Authorities
Our reports have been used by over 10K customers, including:
Immunochemistry Rapid Tests and POC - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Immunochemistry Rapid Tests and POC - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Immunochemistry Rapid Tests & POC pipeline products...
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global dPCR and qPCR Market Report The dPCR and qPCR market by revenue is expected to grow at a CAGR of over 9% during the period 2020–2025. The global digital PCR (dPCR) and the real-time PCR (qPCR) market is one of the dynamic and fast-growing...
Bacteriology Rapid Tests and POC - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Bacteriology Rapid Tests and POC - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Bacteriology Rapid Tests & POC pipeline products with comparative...
G-protein coupled receptors market is anticipated to be driven by rising number of cancer cases, rising prevalence of lifestyle-related issues, such as cardiovascular infections, and respiratory issues. G-protein coupled receptors (GPCRs) are exceptionally helpful in the innovative work of newer medication substances. Furthermore, the increasing...
The RNA analysis/transcriptomics market is projected to reach USD 8.7 billion by 2025 from USD 4.5 billion in 2020, at a CAGR of 13.9% during the forecast period. The growth of this market is majorly driven by the increasing demand for personalized medicine, increasing pharmaceutical and biotechnology R&D expenditure and government funding...
The viral antigens market was valued at US$ 101.41 million in 2019 and is projected to reach US$ 236.80 million by 2027; it is expected to grow at a CAGR of 11.0% during 2020–2027. The growth of the market is attributed to the increased acceptance of viral antigens in vaccine development, and advancements in image analysis software and informatics...
Immunochemistry Analyzers - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Immunochemistry Analyzers - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Immunochemistry Analyzers pipeline products with comparative analysis of...
Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Point-of-Care (POC) Analyzers pipeline products with comparative...
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.